Drug Pipeline

Spesolimab Clinical Trials

Data updated daily from ClinicalTrials.gov — last refresh 2026-06-12
3
Active Studies
1
Recruiting
1
Phase 3
1
Top Sponsors
Active Studies by Phase
Phase 4
1
Phase 3
1
Phase 2
1
Active Trials
NCT IDTitleConditionStatus
Phase 4
NCT06013969 A Study to Test Whether Spesolimab Helps People With Generalized Pustular Psoriasis (GPP)… Generalized Pustular Psoriasis Active, Not Recruiting
Phase 3
NCT06624670 A Study to Test Whether Spesolimab Helps People With a Skin Condition Called Pyoderma… Pyoderma Gangrenosum Recruiting
Phase 2
NCT03886246 Effisayil™ ON: A Study to Test Long-term Treatment With Spesolimab in People With… Generalized Pustular Psoriasis Active, Not Recruiting
Sponsors Running Spesolimab Trials
Boehringer Ingelheim (3)
Disease Areas
Psoriasis (2)
Get alerts when Spesolimab trials change
Status changes, date slips, and new filings — detected daily, delivered to your inbox.
Start monitoring free